Date(s)

17 Aug 2022

Program Language

Portuguese, English

Location

Rio de Janeiro, Brazil

Meeting type

Live Meeting

Organizer

Rio de Janeiro HIV Clinical Forum 2022

Enduring Materials

The presentation videos and slides for speakers lectures will be made available shortly, provided that they have granted us permission to do so.

Session 1 | Antiretroviral Therapy 2022 - State of ART Plenary Lectures -

Highlights of IAS

Claudia Cortes, MD

University of Chile, Chile

Resistance Considerations in Choice of Regimen

Pablo Tebas, MD

University of Pennsylvania, United States of America

Pharmacological Considerations in Choice of Regimen

Ethel D. Weld, MD, PhD

Johns Hopkins University School of Medicine, United States of America

Toxicity & Adherence Considerations in Choice of Regimen

Maria Luisa Alcaide, MD, FIDSA

University of Miami Miller School of Medicine, United States of America

Session 2 | Starting and Switching Antiretroviral Therapy in 2022 -

Update on Therapeutic Options for Starting and Switching

Omar Sued, MSc, MD, PhD

Pan American Health Organization, United States

Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs

Luis E. Soto-Ramírez, MD

Instituto Nacional de Ciencias Médicas y Nutrición, Mexico

HIV Treatment in Children - What Is New?

Cristina Barroso Hofer, MD, PhD

Federal University of Rio de Janeiro, Brazil

Session 3 | Long Acting Antiretrovirals for HIV Prevention and Treatment -

Update on HIV Prevention - The Latest on HPTN 083

Beatriz Grinsztejn, MD, PhD

Instituto de Pesquisa Clinica Evandro Chagas-Fiocruz, Brazil

Therapeutic Options for HIV Treatment for Cis/Trans Women

Romina Oliveira, MD

Instituto de Gestão Estratégica de Saúde do Distrito Federal, Brazil

Clinical Case

Marcio de Figueiredo Fernandes, MD

Universidade Federal do Rio de Janeiro, Brazil

Session 4 | Optimal Care for Underrepresented Populations -

Peculiarities for the Treatment and Prevention of HIV in the Elderly Patient

Richard Elion, MD

Washington Health Institute, United States

Current and Evolving Therapeutic Options for Patients with limited Treatment Options

Ricardo Diaz, MD

Federal University of Sao Paulo - UNIFESP, Brazil

Clinical Case

Tânia Vergara, MD, PhD

Sociedade de Infectologia do Rio de Janeiro Brazil

Overview

Welcome

The Rio de Janeiro HIV Clinical Forum 2022 provided an independent scientific program involving the world’s leading experts and was specifically designed for Brazilian HIV healthcare professionals, focusing on optimizing treatment for their patients. The meeting aimed to increase the knowledge and skills through lectures on novel treatment strategies, long-acting preparations, and the care of complex patients.

This program featured challenging plenary lectures followed by Q&A and debates, stimulating interactions, and the sharing of knowledge within the HIV-treating community. The program included networking opportunities for community building providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to comprehensive HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects. Maintaining these programs in a flexible format through the COVID-19 crisis is crucial for those living with HIV.

Program Director

Mauro Schechter, MD, PhD

Federal University of Rio de Janeiro, Brazil

Local Chair

Tânia Vergara, MD, PhD

Sociedade de Infectologia do Rio de Janeiro Brazil

General Information

COVID-19 Update

The Rio de Janeiro HIV Clinical Forum 2022 was held as a live meeting.

We are available to answer any questions or concerns that you may have about your participation at the Rio de Janeiro HIV Clinical Forum 2022. For more information, please contact Ms. Natalia Voronina at natalia.voronina@amededu.com.

To stay updated on developments about this meeting, make sure that you are signed up for our newsletter.

Who Should Attend?

- Primary: medical doctors involved in the management and treatment of people living with HIV in the region
- Secondary: researchers
- Tertiary: healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV

Meeting Objectives

With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV

Learning Objectives

After participating in the HIV Clinical Forum, participants will be able to:

- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Practical Information

Certificate of Attendance

A certificate of attendance will be sent by e-mail shortly after the forum meeting.

Disclaimer

This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.

Language

The official language of this meeting is Portuguese. English translation will be available.

Liability and Insurance

By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Meeting Materials

An official program and speakers' bios will be sent by e-mail prior to the meeting.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Committees